[1]
Ribeiro, V., Cruz Simões , M.A., Freitas Ribeiro, T., Hildefonso , D.M., Menezes Saldanha Feijó , A., Batista Remígio, G., Vieira Villar, P., Bandoli de Amorim, H., Lima Gaspar Carvalho da Silva , M., Andrade Fantoni, A.L., Gasparetto da Cunha, Y.N. and Faria Teixeira , L. 2024. Use of SGLT2 Inhibitors in the Treatment of Chronic Kidney Disease: Benefits and Clinical Considerations. Brazilian Journal of Implantology and Health Sciences . 6, 9 (Sep. 2024), 3802–3811. DOI:https://doi.org/10.36557/2674-8169.2024v6n9p3802-3811.